« Back
Home /
Sacituzumab govitecan (solution)

Sacituzumab govitecan (solution)

Item no.	HY-132254A-100mg
Manufacturer	MedChem Express
CASRN	1491917-83-9
Amount	100 mg
Quantity options	1 ea 100 mg 10 mg 25 mg 50 mg 5 mg
Specific against	other
Purity	96.02
Dry ice	Yes
Citations	[1]Cardillo TM, et al. Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers. Bioconjug Chem. 2015 May 20;26(5):919-31.<br/>[2]Goldenberg DM, Cardillo TM, Govindan SV, Rossi EA, Sharkey RM. Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC) [published correction appears in Oncotarget. 2020 Mar 10;11(10):942]. Oncotarget. 2015;6(26):22496-22512.
Smiles	[Sacituzumab govitecan (solution)]
Alias	IMMU-132 (solution)
Available
Product Description	Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity[1].
StorageTemperature	-80°C, protect from light
Shipping	Dry Ice
Manufacturers Applications	Cancer-programmed cell death
Clinical Information	Phase 3
Manufacturers Research Area	Cancer
Solubility	10 mM in DMSO
Target	Antibody-Drug Conjugates (ADCs); TROP2
Manufacturers Target	Antibody-Drug Conjugates (ADCs); TROP2
Manufacturers Pathway	Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
Manufacturers Product type	ADC Related

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Request delivery time